Deployment decisions for the Janssen vaccine within the COVID-19 vaccine programme are currently under consideration. The Department will be guided by the advice from the Joint Committee on Vaccination and Immunisation before making a final decision.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4113", "label" : {"_value" : "Biography information for Nadhim Zahawi"} } , "answeringMemberConstituency" : {"_value" : "Stratford-on-Avon"} , "answeringMemberPrinted" : {"_value" : "Nadhim Zahawi"} , "dateOfAnswer" : {"_value" : "2021-06-18", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2021-06-18T12:21:05.58Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2021-06-09", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Coronavirus: Vaccination"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, whether his Department has made an assessment of who should be eligible to receive the Janssen covid-19 vaccine.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4131", "label" : {"_value" : "Biography information for Jim Shannon"} } , "tablingMemberConstituency" : {"_value" : "Strangford"} , "tablingMemberPrinted" : [{"_value" : "Jim Shannon"} ], "uin" : "13066"} , {"_about" : "http://data.parliament.uk/resources/1331269", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1331269/answer", "answerText" : {"_value" : "
The Medicines and Healthcare products Regulatory Agency has undertaken a thorough review into reports of an extremely rare specific type of blood clot in the brain in the United Kingdom, following vaccination with the Oxford/AstraZeneca vaccine. It is also considering other types of blood clots alongside low platelet levels. No risk factors for this unusual type of clotting disorder have been identified although the MHRA is continuing to monitor the emerging data.<\/p>
There is no evidence those with a history of common types of thrombosis are more at risk of developing rare blood clots with low platelets after vaccination. Therefore, the use of the AstraZeneca vaccine in individuals with a history of these conditions is not currently a contraindication. Individuals with past clotting episodes without low platelets and those diagnosed with thrombophilia remain at risk of COVID-19 disease and should be vaccinated with any of the available vaccines. However, as a precautionary measure, administration of the AstraZeneca vaccine in patients with a history of cerebral venous sinus thrombosis or antiphospholipid syndrome should only be considered when the benefit outweighs any potential risks and use is contraindicated in those who have experienced major clots with low platelets after any COVID-19 vaccine or after exposure to heparin.<\/p>
These rare events have also been reported in other countries with the Janssen vaccine. However, no predisposing risk factors have been identified. The available evidence does not suggest an increased risk of these rare events following administration of either the Pfizer/BioNTech or Moderna vaccines.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4113", "label" : {"_value" : "Biography information for Nadhim Zahawi"} } , "answeringMemberConstituency" : {"_value" : "Stratford-on-Avon"} , "answeringMemberPrinted" : {"_value" : "Nadhim Zahawi"} , "dateOfAnswer" : {"_value" : "2021-06-24", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "previousAnswerVersion" : {"_about" : "http://data.parliament.uk/resources/1331269/answer/previousversion/6341", "answeringMember" : {"_about" : "http://data.parliament.uk/members/4113", "label" : {"_value" : "Biography information for Nadhim Zahawi"} } , "answeringMemberConstituency" : {"_value" : "Stratford-on-Avon"} , "answeringMemberPrinted" : {"_value" : "Nadhim Zahawi"} } , "questionFirstAnswered" : [{"_value" : "2021-06-24T10:05:51.563Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2021-06-09", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Coronavirus: Vaccination"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, with reference to (a) pages 22 to 23 of Public Health England's COVID-19 - SARS-CoV-2 Green Book Chapter 14a, published on 7 May 2021, and (b) the Medicines & Healthcare products Regulatory Agency's Information for Healthcare Professionals on COVID-19 Vaccine AstraZeneca, 4.4, published on 15 April 2021, whether he has made an assessment of whether (i) previous experience of thrombosis and (ii) the presence of thrombophilia such as antiphospholipid syndrome should be treated as contraindications for (A) Pfizer/BioNTech, (B) Oxford/AstraZeneca, (C) Moderna and (D) Janssen Covid-19 vaccination in relation to risks of vaccine\u2013induced immune thrombocytopenia and thrombosis.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/1583", "label" : {"_value" : "Biography information for Ms Lyn Brown"} } , "tablingMemberConstituency" : {"_value" : "West Ham"} , "tablingMemberPrinted" : [{"_value" : "Ms Lyn Brown"} ], "uin" : "13001"} , {"_about" : "http://data.parliament.uk/resources/1331347", "AnsweringBody" : [{"_value" : "Department for Business, Energy and Industrial Strategy"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1331347/answer", "answerText" : {"_value" : "
Since the Medicines & Diagnostics Manufacturing Transformation Fund (MDMTF) launched on 7 April this year, we have seen a high level of interest from the sector with a total of 80 registrations visible on the online application portal as of 11th<\/sup> June 2021. The application deadline for the MDMTF is not until 30 June. Once received, applications will be appraised before grant offers are made.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4113", "label" : {"_value" : "Biography information for Nadhim Zahawi"}
}
, "answeringMemberConstituency" : {"_value" : "Stratford-on-Avon"}
, "answeringMemberPrinted" : {"_value" : "Nadhim Zahawi"}
, "dateOfAnswer" : {"_value" : "2021-06-18", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2021-06-18T10:54:02.473Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "201"}
, "answeringDeptShortName" : {"_value" : "Business, Energy and Industrial Strategy"}
, "answeringDeptSortName" : {"_value" : "Business, Energy and Industrial Strategy"}
, "date" : {"_value" : "2021-06-09", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Medicines and Diagnostics Manufacturing Transformation Fund"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Business, Energy and Industrial Strategy, what the uptake has been of funding from the Medicines and Diagnostics Manufacturing Transformation Fund to date.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4488", "label" : {"_value" : "Biography information for Martyn Day"}
}
, "tablingMemberConstituency" : {"_value" : "Linlithgow and East Falkirk"}
, "tablingMemberPrinted" : [{"_value" : "Martyn Day"}
], "uin" : "13145"}
, {"_about" : "http://data.parliament.uk/resources/1331359", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1331359/answer", "answerText" : {"_value" : " Employers are encouraged to discuss whether staff need time off to be vaccinated, as well as adjusting working schedules accordingly to accommodate those who are absent due to receiving the vaccine.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4113", "label" : {"_value" : "Biography information for Nadhim Zahawi"}
}
, "answeringMemberConstituency" : {"_value" : "Stratford-on-Avon"}
, "answeringMemberPrinted" : {"_value" : "Nadhim Zahawi"}
, "dateOfAnswer" : {"_value" : "2021-06-18", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "previousAnswerVersion" : {"_about" : "http://data.parliament.uk/resources/1331359/answer/previousversion/6327", "answeringMember" : {"_about" : "http://data.parliament.uk/members/4113", "label" : {"_value" : "Biography information for Nadhim Zahawi"}
}
, "answeringMemberConstituency" : {"_value" : "Stratford-on-Avon"}
, "answeringMemberPrinted" : {"_value" : "Nadhim Zahawi"}
}
, "questionFirstAnswered" : [{"_value" : "2021-06-18T10:43:47.827Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2021-06-09", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Employment: Coronavirus"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure that workplaces release staff for their covid-19 vaccine.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4471", "label" : {"_value" : "Biography information for Rachael Maskell"}
}
, "tablingMemberConstituency" : {"_value" : "York Central"}
, "tablingMemberPrinted" : [{"_value" : "Rachael Maskell"}
], "uin" : "13126"}
, {"_about" : "http://data.parliament.uk/resources/1331411", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1331411/answer", "answerText" : {"_value" : " Vaccination against COVID-19 is offered to every eligible adult living in the United Kingdom free of charge, regardless of immigration status.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4113", "label" : {"_value" : "Biography information for Nadhim Zahawi"}
}
, "answeringMemberConstituency" : {"_value" : "Stratford-on-Avon"}
, "answeringMemberPrinted" : {"_value" : "Nadhim Zahawi"}
, "dateOfAnswer" : {"_value" : "2021-06-18", "_datatype" : "dateTime"}
, "groupedQuestionUIN" : {"_value" : "13114"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "previousAnswerVersion" : {"_about" : "http://data.parliament.uk/resources/1331411/answer/previousversion/6320", "answeringMember" : {"_about" : "http://data.parliament.uk/members/4113", "label" : {"_value" : "Biography information for Nadhim Zahawi"}
}
, "answeringMemberConstituency" : {"_value" : "Stratford-on-Avon"}
, "answeringMemberPrinted" : {"_value" : "Nadhim Zahawi"}
}
, "questionFirstAnswered" : [{"_value" : "2021-06-18T10:47:20.21Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2021-06-09", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Coronavirus: Vaccination"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, whether people no immigration status are able to access covid-19 vaccinations.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4430", "label" : {"_value" : "Biography information for Alison Thewliss"}
}
, "tablingMemberConstituency" : {"_value" : "Glasgow Central"}
, "tablingMemberPrinted" : [{"_value" : "Alison Thewliss"}
], "uin" : "13113"}
, {"_about" : "http://data.parliament.uk/resources/1331415", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1331415/answer", "answerText" : {"_value" : " Vaccination against COVID-19 is offered to every eligible adult living in the United Kingdom free of charge, regardless of immigration status.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4113", "label" : {"_value" : "Biography information for Nadhim Zahawi"}
}
, "answeringMemberConstituency" : {"_value" : "Stratford-on-Avon"}
, "answeringMemberPrinted" : {"_value" : "Nadhim Zahawi"}
, "dateOfAnswer" : {"_value" : "2021-06-18", "_datatype" : "dateTime"}
, "groupedQuestionUIN" : {"_value" : "13113"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "previousAnswerVersion" : {"_about" : "http://data.parliament.uk/resources/1331415/answer/previousversion/6331", "answeringMember" : {"_about" : "http://data.parliament.uk/members/4113", "label" : {"_value" : "Biography information for Nadhim Zahawi"}
}
, "answeringMemberConstituency" : {"_value" : "Stratford-on-Avon"}
, "answeringMemberPrinted" : {"_value" : "Nadhim Zahawi"}
}
, "questionFirstAnswered" : [{"_value" : "2021-06-18T10:47:20.273Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2021-06-09", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Coronavirus: Vaccination"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, whether people without immigration status will be able to access covid-19 vaccination.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4430", "label" : {"_value" : "Biography information for Alison Thewliss"}
}
, "tablingMemberConstituency" : {"_value" : "Glasgow Central"}
, "tablingMemberPrinted" : [{"_value" : "Alison Thewliss"}
], "uin" : "13114"}
, {"_about" : "http://data.parliament.uk/resources/1331424", "AnsweringBody" : [{"_value" : "Department for Business, Energy and Industrial Strategy"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1331424/answer", "answerText" : {"_value" : " We recognise that this is an unsettling time for Liberty Steel\u2019s workforce. The Government stands ready to support Liberty\u2019s dedicated employees and their families affected by any developments, should the need arise. However, it is first and foremost the responsibility of the company to manage commercial decisions regarding the future of the organisation.<\/p> <\/p> We hope the company is successful in their endeavours in selling these assets. We will continue to engage closely with company and trade unions as the situation develops. Conversations with Liberty or any other company are, of course, commercially confidential<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4113", "label" : {"_value" : "Biography information for Nadhim Zahawi"}
}
, "answeringMemberConstituency" : {"_value" : "Stratford-on-Avon"}
, "answeringMemberPrinted" : {"_value" : "Nadhim Zahawi"}
, "dateOfAnswer" : {"_value" : "2021-06-16", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2021-06-16T15:30:17.213Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "201"}
, "answeringDeptShortName" : {"_value" : "Business, Energy and Industrial Strategy"}
, "answeringDeptSortName" : {"_value" : "Business, Energy and Industrial Strategy"}
, "date" : {"_value" : "2021-06-09", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Liberty Steel: West Midlands"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Business, Energy and Industrial Strategy, what support he plans to provide to people at risk of losing their jobs in Dudley North constituency due to Liberty Steel selling off plants in West Bromwich and Kidderminster.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4789", "label" : {"_value" : "Biography information for Marco Longhi"}
}
, "tablingMemberConstituency" : {"_value" : "Dudley North"}
, "tablingMemberPrinted" : [{"_value" : "Marco Longhi"}
], "uin" : "13236"}
, {"_about" : "http://data.parliament.uk/resources/1331484", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1331484/answer", "answerText" : {"_value" : " Public Health England has issued guidance for healthcare practitioners which states that vaccination should be deferred in those who have tested positive for COVID-19 infection until they have recovered approximately four weeks after the onset of symptoms, or four weeks from the first confirmed positive test in those who are asymptomatic. This guidance is available at the following link:<\/p> <\/p>